Table 2.
Opioid usea | 12-step participationb | |||||||
---|---|---|---|---|---|---|---|---|
Baseline (days prior to treatment) | Post-treatment (% days since discharge) | Lifetime history (any) | Post-treatment (% days since discharge) | |||||
B (95% CI) | β | B (95% CI) | β | OR (95% CI) | B (95% CI) | β | ||
Baseline | ||||||||
Positive coping | −1.56 (−2.55, −.57) | −.44** | – | – | 2.33 (1.21, 4.48)* | – | – | |
Negative coping | −.230 (−1.35, .89) | −.06 | – | – | 1.02 (.70, 1.48) | – | – | |
Changes | ||||||||
Increased positive coping | – | – | .01 (−.03, .05) | .09 | – | 6.98 (.92, 13.05) | .42* | |
Reduced negative coping | – | – | .06 (.02, .10) | .55** | – | −.06 (−6.56, 6.44) | −.00 |
n = 31; 2 participants had missing drug use data at follow-up.
n = 29; 4 participants had missing 12-step data at follow-up
p < .05,
p < .001